ATOSSA THERAPEUTICS, INC. Other Nonoperating Gains (Losses)
ATOSSA THERAPEUTICS, INC. (ATOS) reported Other Nonoperating Gains (Losses) of -$49.91 thousand for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-05-13.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingGainsLosses · last filed 2015-05-13
- ATOSSA THERAPEUTICS, INC. other nonoperating gains (losses) for the quarter ending 2015-03-31 was -$49.91K.
| Period end | Other Nonoperating Gains (Losses) 3 month |
|---|---|
| 2015-03-31 | -$49.91K 10-Q · filed 2015-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |